Furthermore, TGFBI promoter methylation might be useful as a marker for malignant transformation because it was unmethylated in normal melanocytes and hypo- or fully methylated in freshly isolated primary and metastatic melanoma cells, as well as melanoma tumors. The gene discussed is TGFBI; the disease is melanoma.